Cardiac impact of dapagliflozin in advanced chronic kidney disease: rationale and design of the Renal Lifecycle Trial cardiac imaging sub-studies

Micky Karsten, Sunil V Badve, Ron T Gansevoort, Stefan P Berger, Hiddo J L Heerspink, Alferso C Abrahams, Laurent Billot, Rianne H A C M Bon, Mariëlle A C J Gelens, Dean Guinness, Christian Hamilton-Craig, Loek van Heerebeek, Marc H Hemmelder, Lauren Houston, Rebecca Kozor, Dirk R J Kuypers, Helen Monaghan, Bruce Neal, Brendon L Neuen, James Otton, Vlado Perkovic, Adil Rajwani, Angela Y Wang, Marc G Vervloet, Clare Arnott, Lily Jakulj, Unknown, Ronald van Etten, Karlien Francois, Pedro Gois, Joost van der Heijden, Jane Holt, Shilpa Jesudason, Karen Keung, Yu Sok Kim, Rathika Krishnasamy, Hemant Kulkarni, Joep van der Leeuw, Angela Makris, Rosemary Masterson, Amanda Mather, Gurbey Ocak, Dharmenaan Palamuthusingam, Eugenia Pedagogos, Carl Siegert, Brendan Smyth, Vikas Srivastava, Girish Talaulikar, Rowena Vleut, Femke Waanders, Germaine Wong, Muh Geot Wong, Kate Wyburn

Open source

DOI
10.1093/ckj/sfaf376
Published
2025-12-02
Container
Clinical Kidney Journal
Publisher
Oxford University Press (OUP)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/ckj/sfaf376,
  title = {Cardiac impact of dapagliflozin in advanced chronic kidney disease: rationale and design of the Renal Lifecycle Trial cardiac imaging sub-studies},
  author = {Micky Karsten and Sunil V Badve and Ron T Gansevoort and Stefan P Berger and Hiddo J L Heerspink and Alferso C Abrahams and Laurent Billot and Rianne H A C M Bon and Mariëlle A C J Gelens and Dean Guinness and Christian Hamilton-Craig and Loek van Heerebeek and Marc H Hemmelder and Lauren Houston and Rebecca Kozor and Dirk R J Kuypers and Helen Monaghan and Bruce Neal and Brendon L Neuen and James Otton and Vlado Perkovic and Adil Rajwani and Angela Y Wang and Marc G Vervloet and Clare Arnott and Lily Jakulj and Unknown and Ronald van Etten and Karlien Francois and Pedro Gois and Joost van der Heijden and Jane Holt and Shilpa Jesudason and Karen Keung and Yu Sok Kim and Rathika Krishnasamy and Hemant Kulkarni and Joep van der Leeuw and Angela Makris and Rosemary Masterson and Amanda Mather and Gurbey Ocak and Dharmenaan Palamuthusingam and Eugenia Pedagogos and Carl Siegert and Brendan Smyth and Vikas Srivastava and Girish Talaulikar and Rowena Vleut and Femke Waanders and Germaine Wong and Muh Geot Wong and Kate Wyburn},
  year = {2025},
  journal = {Clinical Kidney Journal},
  doi = {10.1093/ckj/sfaf376},
  url = {https://doi.org/10.1093/ckj/sfaf376}
}

RIS

TY  - JOUR
TI  - Cardiac impact of dapagliflozin in advanced chronic kidney disease: rationale and design of the Renal Lifecycle Trial cardiac imaging sub-studies
AU  - Micky Karsten
AU  - Sunil V Badve
AU  - Ron T Gansevoort
AU  - Stefan P Berger
AU  - Hiddo J L Heerspink
AU  - Alferso C Abrahams
AU  - Laurent Billot
AU  - Rianne H A C M Bon
AU  - Mariëlle A C J Gelens
AU  - Dean Guinness
AU  - Christian Hamilton-Craig
AU  - Loek van Heerebeek
AU  - Marc H Hemmelder
AU  - Lauren Houston
AU  - Rebecca Kozor
AU  - Dirk R J Kuypers
AU  - Helen Monaghan
AU  - Bruce Neal
AU  - Brendon L Neuen
AU  - James Otton
AU  - Vlado Perkovic
AU  - Adil Rajwani
AU  - Angela Y Wang
AU  - Marc G Vervloet
AU  - Clare Arnott
AU  - Lily Jakulj
AU  - Unknown
AU  - Ronald van Etten
AU  - Karlien Francois
AU  - Pedro Gois
AU  - Joost van der Heijden
AU  - Jane Holt
AU  - Shilpa Jesudason
AU  - Karen Keung
AU  - Yu Sok Kim
AU  - Rathika Krishnasamy
AU  - Hemant Kulkarni
AU  - Joep van der Leeuw
AU  - Angela Makris
AU  - Rosemary Masterson
AU  - Amanda Mather
AU  - Gurbey Ocak
AU  - Dharmenaan Palamuthusingam
AU  - Eugenia Pedagogos
AU  - Carl Siegert
AU  - Brendan Smyth
AU  - Vikas Srivastava
AU  - Girish Talaulikar
AU  - Rowena Vleut
AU  - Femke Waanders
AU  - Germaine Wong
AU  - Muh Geot Wong
AU  - Kate Wyburn
PY  - 2025
JO  - Clinical Kidney Journal
DO  - 10.1093/ckj/sfaf376
UR  - https://doi.org/10.1093/ckj/sfaf376
ER  - 

APA

Karsten, M., Badve, S. V., Gansevoort, R. T., Berger, S. P., Heerspink, H. J. L., Abrahams, A. C., Billot, L., Bon, R. H. A. C. M., Gelens, M. A. C. J., Guinness, D., Hamilton-Craig, C., Heerebeek, L. V., Hemmelder, M. H., Houston, L., Kozor, R., Kuypers, D. R. J., Monaghan, H., Neal, B., Neuen, B. L., Otton, J., Perkovic, V., Rajwani, A., Wang, A. Y., Vervloet, M. G., Arnott, C., Jakulj, L., Unknown, Etten, R. V., Francois, K., Gois, P., Heijden, J. V. D., Holt, J., Jesudason, S., Keung, K., Kim, Y. S., Krishnasamy, R., Kulkarni, H., Leeuw, J. V. D., Makris, A., Masterson, R., Mather, A., Ocak, G., Palamuthusingam, D., Pedagogos, E., Siegert, C., Smyth, B., Srivastava, V., Talaulikar, G., Vleut, R., Waanders, F., Wong, G., Wong, M. G., & Wyburn, K. (2025). Cardiac impact of dapagliflozin in advanced chronic kidney disease: rationale and design of the Renal Lifecycle Trial cardiac imaging sub-studies. Clinical Kidney Journal. https://doi.org/10.1093/ckj/sfaf376

Source records